Why is Onyx Biotec falling/rising?

As of 24-Sep, Onyx Biotec Ltd is currently priced at 45.80, showing no change (0.00%). The stock has underperformed in the past week, declining by 6.53%, and has also seen a significant year-to-date drop of 23.03%. Today's performance indicates that the stock has outperformed its sector by 0.45%, but it is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. Additionally, there has been a notable decrease in investor participation, with delivery volume falling by 87.95% compared to the 5-day average. Unfortunately, there is no information available regarding positive or negative factors that could further explain the stock's recent movement.
In the broader market context, Onyx Biotec's short-term performance has been significantly worse than the benchmark, with the Sensex only declining by 1.08% over the past week and gaining 5.97% year-to-date. This stark contrast highlights the challenges faced by Onyx Biotec in attracting investor interest, especially given the broader market's relatively stable performance. The liquidity of the stock remains adequate for trading, but the sharp decline in delivery volume suggests a lack of confidence among investors, contributing to the stock's downward trajectory.